コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 equivalent between free drug and drug loaded nanoemulsion.
2 BHT in increasing the stability of lycopene nanoemulsion.
3 ormulated with a novel oil-in-water cationic nanoemulsion.
4 de micelles or corresponding perfluorocarbon nanoemulsions.
5 res by preparing fluorescent perfluorocarbon nanoemulsions.
6 to examine the possible hepatic toxicity of nanoemulsions.
7 relatively high ( approximately 66%) in LCT nanoemulsions.
8 he Ostwald ripening commonly associated with nanoemulsions.
9 of these AOT stabilized regular and reverse nanoemulsions.
10 rent physico-chemical characteristics of O/W nanoemulsions.
11 Trolox increased the oxidative stability of nanoemulsions (100 MPa) and acted synergistically with B
14 cellular uptake of lutein by Caco-2 cells in nanoemulsions (872.9+/-88.3pmol/mgprotein) than conventi
15 ine antigen, ID93, formulated in a synthetic nanoemulsion adjuvant, GLA-SE, administered in combinati
16 olecular imaging signatures of the presented nanoemulsions allow for future in vivo monitoring of the
25 mulated these fluorinated ligands as aqueous nanoemulsions, and then metallated them with various tra
26 However, under the same condition anise oil nanoemulsion (AO75) reduced E. coli O157:H7 and L. monoc
30 stability and rheology of 5wt% oil-in-water nanoemulsions as a function of lentil protein isolate co
31 ngly support the future use of the presented nanoemulsions as anti-COX-2 theranostic nanomedicine wit
32 potential to be utilized as an emulsifier in nanoemulsions, as well as in the formation of emulsion g
33 njected dose/ml) as compared to the cationic nanoemulsion (AUClast in plasma - 20.2+/-1.86min*%/injec
34 incorporation of hydrophobic molecules into nanoemulsion based-delivery systems may therefore enable
35 trol could be encapsulated within low-energy nanoemulsion-based delivery systems and protected agains
36 nd therefore has great potential for forming nanoemulsion-based delivery systems for food, personal c
37 des important information for development of nanoemulsion-based delivery systems that increase oral b
38 e useful information for designing effective nanoemulsion-based delivery systems that retard the chem
41 The purpose of this study was to develop nanoemulsion-based systems to deliver hydrophobic molecu
44 negligible ( approximately 0%) in orange oil nanoemulsions because no mixed micelles were formed to s
45 be encapsulated in the VE/VE2-PEG2000/water nanoemulsions because of favorable hydrophobic interacti
46 as relatively low ( approximately 2%) in MCT nanoemulsions because the mixed micelles formed were too
47 icelles with elastic cores and corresponding nanoemulsions both manifest high therapeutic efficacy, w
48 thin improved the physical properties of EOC nanoemulsions but did not improve antimicrobial activiti
49 dy was to prepare canola oil based vitamin E nanoemulsions by using food grade mixed surfactants (Twe
51 The results of this study indicated that nanoemulsions can be used as a delivery system to improv
52 lope glycoprotein formulated with a cationic nanoemulsion (CNE) delivery system was evaluated in rhes
53 after exposure to UV-light: 88% retention in nanoemulsions compared to 50% in dimethylsulphoxide (DMS
54 mesoporous organohydrogels from oil-in-water nanoemulsions containing an end-functionalized oligomeri
55 of C. elegans when they were incubated with nanoemulsions containing conjugated linoleic acid, which
58 was more effective at promoting oxidation in nanoemulsions containing small droplets because light wa
62 ensis) was formulated as a water-dispersible nanoemulsion (diameter=143nm) using high-intensity ultra
66 different nanoparticle systems, for example, nanoemulsions, drug-loaded block-copolymer micelles, and
67 lex relationship on LCT content for high fat nanoemulsions, due to the opposing effects of lipid dige
69 especially evident when either a bioadhesive nanoemulsion (emulsomes) or cholera toxin B subunit (CTB
70 formulation of unique perfluorocarbon (PFC) nanoemulsions enabling intracellular pH measurements in
73 oth manifest high therapeutic efficacy, with nanoemulsions exerting lower systemic toxicity than mice
75 y stable, nontoxic perfluoropolyether (PFPE) nanoemulsions for dual 19F MRI-fluorescence detection.
77 tivity of the essential oil in both pure and nanoemulsion forms was measured against an important foo
79 ors treated with either PEG-PDLA micellar or nanoemulsion formulation recurred after the completion o
80 l fraction of micelles with elastic cores in nanoemulsion formulations is desirable for prevention of
82 orable hydrophobic interactions; second, the nanoemulsions had a long blood circulation time; finally
86 treal injection of 2-Methoxyestradiol (2-ME) nanoemulsion in regressing neovascularization of a ROP r
88 ults showed that the encapsulation of flavor nanoemulsions in filled hydrogels reduces the release of
89 systems also demonstrated the capability of nanoemulsions in sustained release of resveratrol from d
90 ere thymol was efficiently encapsulated, the nanoemulsions inhibited Botrytis cinerea at 110ppm of th
92 Intravitreal injection of 2-Methoxyestradiol nanoemulsion is a promising effective method in reductio
93 cs of microbial deactivation showed that the nanoemulsion killed all the bacteria in about 5min, wher
101 Nasal administration of an oil-in-water nanoemulsion (NE) adjuvant W805EC produces potent system
103 or CpG ODN or a squalene-based oil-in-water nanoemulsion (NE)], upon administration during the secon
104 iH(3)F(8) drastically slowed the ripening of nanoemulsions of the commonly used fluorinated anestheti
105 ithin mixture resulted in stable translucent nanoemulsions of thymol and eugenol with spherical dropl
106 sed on the formulation of oil-in-water (O/W) nanoemulsions of WBO in order to improve the bioaccessib
109 peptide (alpha2AP)-targeted perfluorocarbon nanoemulsions (PFCs) as contrast agent, which is cross-l
110 size and lutein encapsulation efficiency of nanoemulsions prepared by emulsification and solvent eva
111 the particle size and stability of vitamin D nanoemulsions prepared by spontaneous emulsification (SE
112 vitamin D3 encapsulated within oil-in-water nanoemulsions prepared using a natural surfactant (quill
114 (EOCs) in aqueous systems, properties of EOC nanoemulsions prepared with a LAE and lecithin mixture w
115 nance imaging (MRI) employ intracellular PFC nanoemulsion probes to track cells using (19)F MRI.
119 inkable gelators enables the freezing of the nanoemulsion's microstructure into a soft hydrogel nanoc
120 nanoemulsion and the CREKA-peptide-modified nanoemulsion showed a higher relative targeting efficien
123 orage at 23 degrees C; whereas MS stabilized nanoemulsions showed significant increases in MDD and tu
125 he potential of utilising oil-in-water (O/W) nanoemulsions stabilised by a globular protein (beta-lac
126 understanding the PFC cell loading dynamics, nanoemulsion stability and cell viability over time.
127 he experimental values for particle size and nanoemulsion stability were 156.13+/-2.3nm and 0.328+/-0
128 -Carotene was incorporated into oil-in-water nanoemulsions stabilized by either a globular protein (b
130 ar (oil in water) and reverse (water in oil) nanoemulsions stabilized with the surfactant dioctyl sod
132 urfactant assembly at these relatively large nanoemulsion surfaces and allow for an important compari
133 ng 17-betaE using the CREKA-peptide-modified nanoemulsion system (AUClast in plasma - 263.89+/-21.81m
134 e-Alanine) omega-3-fatty acid oil containing nanoemulsion system in vivo in the wild type C57BL/6 mic
135 the study shows that CREKA-peptide-modified nanoemulsion system was the most suitable vehicle for sy
136 was observed with the CREKA-peptide-modified nanoemulsion system, the study shows that CREKA-peptide-
137 he particles are prepared by an oil-in-water nanoemulsion technique without the need of additional de
139 to direct, mass production of robust double nanoemulsions that are amenable to nanostructured encaps
140 ymer delivery system to encapsulate flavored nanoemulsions that are released under artificial saliva
141 Here we report multifunctional celecoxib nanoemulsions that can be imaged by both near-infrared f
145 njections of PTX-loaded PEG-PDLA micelles or nanoemulsions to pancreatic tumor bearing mice resulted
150 ctant free, olive-oil based alpha tocopherol nanoemulsions, using a food grade non-ionic surfactant.
151 and bioaccessibility of beta-carotene-loaded nanoemulsions, using a simulated digestion process.
155 ls loaded with nanoemulsion, the local pH of nanoemulsions was longitudinally quantified using optica
157 The biodegradation of PEG-PDLA stabilized nanoemulsions was monitored by the ultrasonography of na
160 he spectral and pH-sensing properties of the nanoemulsions were characterized in vitro and showed the
161 (<-5 mV) at pH 3.6 indicating MS stabilized nanoemulsions were destabilized by coalescence due to in
168 incorporated in the oil phase, QS stabilized nanoemulsions were stable during 2 weeks of storage at 2
172 t to the treatment with PEG-PLLA micelles or nanoemulsions where all resolved tumors quickly recurred
173 tants for stability; the formation of double nanoemulsions, where both inner and outer droplets are u
174 t efficient formulations were lecithin-based nanoemulsions which were able to transport resveratrol t
175 ed considerably when it was converted into a nanoemulsion, which was attributed to easier access of t
176 ol was encapsulated in the inner core of the nanoemulsions, which provides protection against chemica
177 within the lipid phase increased for low fat nanoemulsions, which was attributed to the increased sol
178 QS was found superior to MS in fabricating nanoemulsion with smallest MDD of 69 nm and turbidity of
180 Optical microscopy showed that oil-in-water nanoemulsions with a range of particle diameters (40-500
183 ibe the formulation of perfluorocarbon-based nanoemulsions with improved sensitivity for cellular MRI
185 Iron(III) tris-beta-diketonate ('FETRIS') nanoemulsions with PFPE have low cytotoxicity (<20%) and
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。